iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report) was the target of a large decrease in short interest during the month of August. As of August 14th, there was short interest totaling 3,452 shares, a decrease of 56.3% from the July 30th total of 7,895 shares. Based on an average daily trading volume, of 4,508 shares, the short-interest ratio is currently 0.8 days. Currently, 2.3% of the shares of the company are sold short.
iShares Neuroscience and Healthcare ETF Stock Down 2.7%
Shares of iShares Neuroscience and Healthcare ETF stock traded down $1.07 on Friday, hitting $39.23. The stock had a trading volume of 4,007 shares, compared to its average volume of 2,328. The stock has a market cap of $5.88 million, a price-to-earnings ratio of 15.61 and a beta of 0.75. iShares Neuroscience and Healthcare ETF has a twelve month low of $25.00 and a twelve month high of $43.01. The business’s 50 day moving average is $38.54 and its two-hundred day moving average is $35.29.
About iShares Neuroscience and Healthcare ETF
Further Reading
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
